1.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 19 and over
Sponsor: Other
Protocol IDs: 01-002-0601, NCT00205751
|
|
2.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 06762004, NCT00420888
|
|
3.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: ECOG-1697, SWOG-E1697, CALGB-500103, CAN-NCIC-ME10, COG-E1697, E1697, NCT00003641, ME10
|
|
4.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: Any age
Sponsor: Other
Protocol IDs: III-MK-CML-IV, EU-20248, NCT00055874
|
|
5.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: A6181034, NCT00083889
|
|
6.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 60 and over
Sponsor: Other
Protocol IDs: MCL2004-1, NCT00209209
|
|
7.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: UTHSC-MS-99116, NCI-V99-1561, NCT00004063
|
|
8.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: immatureDC- HMO-CTIL, NCT00278018
|
|
9.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: MM0413, NCT00197912
|
|
10.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 12 and over
Sponsor: NCI
Protocol IDs: NCI-94-C-0074, NCI-MB-325, NCT00018993
|
|
11.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: Over 18
Sponsor: NCI
Protocol IDs: OSU-01H0185, NCI-2669, NCT00026221, 2669
|
|
12.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: ICRF-C00.204, EU-20129, NCT00027664
|
|
13.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: MDA-ID-02040, NCT00068575
|
|
14.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: UTHSC-MS-02117, NCT00082862
|
|
15.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: CINJ-100101, NJ 1703, CINJ-3390, CINJ-NJ1703, NCT00138151
|
|
16.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: UMN-2004LS060, UMN-2743RO, NCT00262951
|
|
17.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: 1747CTIL, Raphael Rubinov, NCT00226798
|
|
18.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: No age specified
Sponsor: Other
Protocol IDs: HSC-MS-04-259, NCT00178698
|
|
19.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: JHOC-J05121, J05121, NCT00363649
|
|
20.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 5 to 70
Sponsor: Other
Protocol IDs: P96-221, NCT00504140
|
|
21.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 13 to 70
Sponsor: Other
Protocol IDs: DM03-0218, NCT00505635
|
|
22.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: IRB07124, IST14087, NCT00761241
|
|
23.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: LNH-Pro-05, EudraCT Number:2005-004761-42, NCT00842114
|
|
24.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 12 to 70
Sponsor: Other
Protocol IDs: 0457-08-HMO-CTIL, NCT00855452
|
|
25.
|
Phase: Phase I
Type: Treatment
Status: Active
Age: Not specified
Sponsor: NCI
Protocol IDs: MDA-ID-030172, NCT00082719
|
